Posted on Friday, 18th November 2011 by Marcus Gollan
A researcher collaboration between scientists at University of Colorado–Denver and Technion–Israel Institute of Technology has successfully tested a gold nanoparticle (GNP)-based sensor that can detect lung cancer (LC) markers in a patients breath. The technology, which weve been following at Medgadget for a few years now (see flashbacks below), is able to rapidly identify small molecule volatile organic compounds that might point to the presence of lung cancer.
The team compared the sensor to gas chromatography–mass spectrometry identification finding that the new device provided significant discrimination between (i) LC and healthy states; (ii) small cell LC and non–small cell LC; and between (iii) two subtypes of non–small cell LC: adenocarcinoma and squamous cell carcinoma.
The researchers believe the new technology will not only help with diagnosing LC, but with monitoring how specific treatments are benefiting the patient.
Similar Posts:
- Nanopore-Based microRNA Sensor for Early Diagnosis of Lung Cancer
- New Funding Opportunities to Assist Innovative Small Businesses Announced: NCI News Note
- NHS Approves BD FocalPoint for Automated Cervical Cancer Screening
- Talk Back: CT scans, mammograms, Avastin, Provenge: Who pays?
- Ultrasonic scalpel causes greater depth of soft tissue necrosis compared to monopolar electrocautery at standard power level settings in a pig model
Tags: Gold Nanoparticle, Sensor
Posted in Health Notes | No Comments »